Recursion Pharmaceuticals, Inc. - Class A Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 06/05/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 06/05/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/08/2025 | Mar 2024Filed 05/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $7.7 | $6.5 | $5.2 | $19 | $15 | $26 | $14 | $14 | |
| −$131 | −$118 | −$162 | −$172 | −$202 | −$96 | −$98 | −$91 | |
| −$0.25 | −$0.22 | −$0.36 | −$0.41 | −$0.50 | −$0.34 | −$0.40 | −$0.39 | |
| 532 | 529 | 447 | 417 | 403 | 283 | 242 | 236 |
Trend